Pfizer starts Omicron-specific COVID-19 vaccine trial
The Hindu
The trial will involve 1,420 people aged 18-55.
Pfizer and its partner BioNTech have begun enrolment for a clinical trial to test the safety and immune response of their Omicron-specific COVID-19 vaccine in adults aged up to 55, the companies said in a statement on January 25.
Pfizer’s CEO Albert Bourla has previously said that the pharmaceutical giant could be ready to file for regulatory approval of the shot by March.

VinFast’s entry into India is a strategic one, and it comes with real investment. The company is setting up a manufacturing facility in Tuticorin, Tamil Nadu, with an initial capacity of 50,000 vehicles per year, scalable to 150,000 units annually. With an investment of up to USD 500 million, this is not a soft launch—it is a full-fledged push into what is one of the world’s most promising auto markets.

On June 7, 1742, Prussian mathematician Christian Goldbach wrote a letter to Swiss polymath Leonhard Euler. Why does it warrant attention, you seem to be asking. Goldbach outlined a conjecture that bears his name in this letter, a conjecture that is now one of the oldest and most famous unsolved problems in all of number theory. Intrigued? A.S.Ganesh hands you more details about Goldbach and Goldbach’s conjecture…